BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 21801600)

  • 1. Metabolic alterations in cancer cells and therapeutic implications.
    Hammoudi N; Ahmed KB; Garcia-Prieto C; Huang P
    Chin J Cancer; 2011 Aug; 30(8):508-25. PubMed ID: 21801600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
    Zhang Y; Yang JM
    Cancer Biol Ther; 2013 Feb; 14(2):81-9. PubMed ID: 23192270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Warburg effect and its cancer therapeutic implications.
    Chen Z; Lu W; Garcia-Prieto C; Huang P
    J Bioenerg Biomembr; 2007 Jun; 39(3):267-74. PubMed ID: 17551814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity.
    Catalán M; Olmedo I; Faúndez J; Jara JA
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered glutamine metabolism and therapeutic opportunities for lung cancer.
    Mohamed A; Deng X; Khuri FR; Owonikoko TK
    Clin Lung Cancer; 2014 Jan; 15(1):7-15. PubMed ID: 24377741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria Targeting as an Effective Strategy for Cancer Therapy.
    Ghosh P; Vidal C; Dey S; Zhang L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of the Warburg effect in cancer cell biology.
    Bensinger SJ; Christofk HR
    Semin Cell Dev Biol; 2012 Jun; 23(4):352-61. PubMed ID: 22406683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
    Levine AJ; Puzio-Kuter AM
    Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to the Future: Therapeutic Targeting of Cancer Cell Metabolism.
    Gilmour R; Velasco S
    SLAS Discov; 2017 Apr; 22(4):333-337. PubMed ID: 28328320
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and brain cancer.
    Marie SK; Shinjo SM
    Clinics (Sao Paulo); 2011; 66 Suppl 1(Suppl 1):33-43. PubMed ID: 21779721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell metabolism: target for cancer therapy.
    Chae YC; Kim JH
    BMB Rep; 2018 Jul; 51(7):319-326. PubMed ID: 29764565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell theory and the warburg effect, two sides of the same coin?
    Pacini N; Borziani F
    Int J Mol Sci; 2014 May; 15(5):8893-930. PubMed ID: 24857919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Links between cancer metabolism and cisplatin resistance.
    Cocetta V; Ragazzi E; Montopoli M
    Int Rev Cell Mol Biol; 2020; 354():107-164. PubMed ID: 32475471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
    Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
    Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.